In particular, NF-κB induces CXCR4 expression in tumor cells32, and we observed that cell surface CXCR4 expression in breast cancer cells is partially reduced by treatment with an NF-κB inhibitor (unpublished results). Here, NFKB1 is linked to breast carcinoma.